31 search results for: CRSwNP

ADVENT On Air | Loss of Smell in <b>CRSwNP</b> Patients
Rhinology
ADVENT On Air | Loss of Smell in CRSwNP Patients
Podcast

Profs. Wytske Fokkens and Joaquim Mullol discuss the clinical significance of the loss of smell in patients with CRSwNP.

View more
IFOS 2023 | Type 2 Inflammation and Clinically Relevant Improvements in <b>CRSwNP</b>
On Demand
IFOS 2023 | Type 2 Inflammation and Clinically Relevant Improvements in CRSwNP

Dr. Stella Lee and Profs. Peter Hellings and Wytske Fokkens discuss type 2 inflammation, partnering with patients to improve outcomes, and real-world data on biologic effectiveness in CRSwNP.

Partnering With Patients: Scores That Matter in <b>CRSwNP</b>
Rhinology
Partnering With Patients: Scores That Matter in CRSwNP
interactivity

Learn how partnering with patients and considering the clinical relevance of symptom improvements can improve patient quality of life

View more
World Anosmia Awareness Day
On Demand
World Anosmia Awareness Day

Explore our educational resources about loss of smell and the role of type 2 inflammation in CRSwNP, featuring expert insights from Profs. Wytske Fokkens and Joaquim Mullol.

<b>CRSwNP</b> Interactive Patient Case Tool
Rhinology
CRSwNP Interactive Patient Case Tool
interactivity

Meet Fernando. Journey through his clinical profile, applying guideline-based checklists to reach a consensus regarding his diagnosis.

View more
ADVENT at EAACI 2025
Congress
13
June
2025
Congress
ADVENT at EAACI 2025

Join Profs. Brian Lipworth, Zuzana Diamant, and Philippe Gevaert at an sponsored symposium about the latest strategies for the management of co-existing type 2 asthma and severe and/or uncontrolled CRSwNP.

EAACI 2024 | On-Treatment Clinical Remission in Upper and Lower Airways: ​ Going Beyond Symptom Control​
Congress
31
May
2024
Congress
EAACI 2024 | On-Treatment Clinical Remission in Upper and Lower Airways: ​ Going Beyond Symptom Control​

Join experts G. Walter Canonica, Vibeke Backer, and Joaquim Mullol for an educational symposium on elevating treatment goals from control to remission in the upper and lower airways.